128
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

3D-QSAR and Molecular Docking Analysis for Natural Aurone Derivatives as Anti-Malarial Agents

ORCID Icon, &
Pages 6017-6032 | Received 19 Mar 2021, Accepted 09 Aug 2021, Published online: 02 Sep 2021

References

  • Constantianus J. M. Koenraadt and Willem Takken, “Integrated Approach to Malaria Control,” Science (New York, N.Y.) 359, no. 6375 (2018): 528–9.
  • Elizabeth Ashley, Rose McGready, Stephane Proux, and François Nosten, “Malaria,” Travel Medicine and Infectious Disease 4, no. 3–4 (2006): 159–73.
  • Michael L. Wilson, Kenneth A. Fleming, Modupe A. Kuti, Lai Meng Looi, Nestor Lago, and Kun Ru, “Access to Pathology and Laboratory Medicine Services: A Crucial Gap,” The Lancet 391, no. 10133 (2018): 1927–38.
  • Benjamin Mordmüller, Güzin Surat, Heimo Lagler, Sumana Chakravarty, Andrew S. Ishizuka, Albert Lalremruata, Markus Gmeiner, Joseph J. Campo, Meral Esen, Adam J. Ruben, et al., “Sterile Protection against Human Malaria by Chemoattenuated PfSPZ Vaccine,” Nature 542, no. 7642 (2017): 445–9.
  • M. Schlitzer, “Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently used Therapeutics, and Drugs in Clinical Development,” ChemMedChem, 2, no. 7 (2007): 944–86.
  • Chanaki Amaratunga, Pharath Lim, Seila Suon, Sokunthea Sreng, Sivanna Mao, Chantha Sopha, Baramey Sam, Dalin Dek, Vorleak Try, Roberto Amato, et al. “Dihydroartemisinin–Piperaquine Resistance in Plasmodium falciparum Malaria in Cambodia: A Multisite Prospective Cohort Study,” The Lancet. Infectious Diseases 16, no. 3 (2016): 357–65.
  • Ellen Bushell, Ana Rita Gomes, Theo Sanderson, Burcu Anar, Gareth Girling, Colin Herd, Tom Metcalf, Katarzyna Modrzynska, Frank Schwach, Rowena E. Martin, et al. “Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes,”Cell 170, no. 2 (2017): 260–72.e8.
  • Andrew Hammond, Roberto Galizi, Kyros Kyrou, Alekos Simoni, Carla Siniscalchi, Dimitris Katsanos, Matthew Gribble, Dean Baker, Eric Marois, Steven Russell, et al. “A CRISPR-Cas9 Gene Drive System Targeting Female Reproduction in the Malaria Mosquito Vector Anopheles gambiae,” Nature Biotechnology 34, no. 1 (2016): 78–83.
  • David T. Riglar, Dave Richard, Danny W. Wilson, Michelle J. Boyle, Chaitali Dekiwadia, Lynne Turnbull, Fiona Angrisano, Danushka S. Marapana, Kelly L. Rogers, Cynthia B. Whitchurch, et al. “Super-Resolution Dissection of Coordinated Events during Malaria Parasite Invasion of the Human Erythrocyte,” Cell Host & Microbe 9, no. 1 (2011): 9–20.
  • Karen S. Anderson, “Understanding the Molecular Mechanism of Substrate Channeling and Domain Communication in Protozoal Bifunctional TS-DHFR,” Protein Engineering, Design & Selection: PEDS 30, no. 3 (2017): 253–63.
  • Paola Favuzza, Manuel de Lera Ruiz, Jennifer K. Thompson, Tony Triglia, Anna Ngo, Ryan W. J. Steel, Marissa Vavrek, Janni Christensen, Julie Healer, Christopher Boyce, et al. “Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle,” Cell Host & Microbe 27, no. 4 (2020): 642–58.e12.
  • Ghaneya Hassan, Hanan Georgey, Riham George, and Eman Mohamed, “Aurones and Furoaurones: Biological Activities and Synthesis,” Bulletin of Faculty of Pharmacy, Cairo University 56, no. 2 (2018): 121–7.
  • Marta P. Carrasco, Marta Machado, Lídia Gonçalves, Moni Sharma, Jiri Gut, Amanda K. Lukens, Dyann F. Wirth, Vânia André, Maria Teresa Duarte, Rita C. Guedes, et al. “Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites,” ChemMedChem. 11, no. 19 (2016): 2194–204.
  • Amad Uddin, Vigyasa Singh, Iram Irfan, Taj Mohammad, Rahul Singh Hada, Md Imtaiyaz Hassan, Mohammad Abid, and Shailja Singh, “Identification and Structure-Activity Relationship (SAR) Studies of Carvacrol Derivatives as Potential Anti-Malarial against Plasmodium falciparum Falcipain-2 Protease,” Bioorganic Chemistry 103 (2020): 104142.
  • Abdulla Al Mamun, Zheng Mei, Ling Qiu, and Xue-hai Ju, “Theoretical Investigation on QSAR of (2-Methyl-3-Biphenylyl) Methanol Analogs as PD-L1 Inhibitor,” Chinese Journal of Chemical Physics 33, no. 4 (2020): 459–67.
  • Jian-Bo. Tong, Ding. Luo, Hai-Yin. Xu, Shuai. Bian, Xing. Zhang, Xue-Chun. Xiao, and Jie. Wang, “A Computational Approach for Designing Novel SARS-CoV-2 Mpro Inhibitors: combined QSAR, Molecular Docking, and Molecular Dynamics Simulation Techniques,”New Journal of Chemistry 45no. 26 (2021): 11512–29. no.
  • Fereshteh Shiri, Alireza Shahraki, and Massoud Nejati-Yazdinejad, “3D-QSAR and Molecular Docking Study on Maleimide-Based Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis,” Polycyclic Aromatic Compounds 40, no. 3 (2020): 743–57.
  • Yu-Liang Wang, Fan Wang, Xing-Xing Shi, Chen-Yang Jia, Feng-Xu Wu, Ge-Fei Hao, and Guang-Fu Yang, “Cloud 3D-QSAR: A Web Tool for the Development of Quantitative Structure–Activity Relationship Models in Drug Discovery,” Briefings in Bioinformatics 22, no. 3 (2021): bbaa276.
  • Richard Cramer, D. Patterson, and J. Bunce, “ChemInform Abstract: Comparative Molecular Field Analysis (CoMFA). Part 1. Effect of Shape on Binding of Steroids to Carrier Proteins,”ChemInform 19, no. 51 (1988). doi: 10.1002/chin.198851058
  • G. Klebe, U. Abraham, and T. Mietzner, “Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological activity,” Journal of Medicinal Chemistry 37, no. 24 (1994): 4130–46.
  • Daniel Gedder Silva, Josmar Rodrigues Rocha, Geraldo Rodrigues Sartori, and Carlos Alberto Montanari, “Highly Predictive Hologram QSAR Models of Nitrile-Containing Cruzain Inhibitors,” Journal of Biomolecular Structure & Dynamics 35, no. 15 (2017): 3232–49.
  • Garrett M. Morris and Marguerita Lim-Wilby, “Molecular Docking,” Methods in Molecular Biology (Clifton, N.J.) 443 (2008): 365–82.
  • Florence Souard, Sabrina Okombi, Chantal Beney, Severine Chevalley, Alexis Valentin, and Ahcene Boumendjel, “1-Azaaurones Derived from the Naturally Occurring Aurones as Potential Antimalarial Drugs,” Bioorganic & Medicinal Chemistry 18, no. 15 (2010): 5724–31.
  • Ahmad Akrami and Ali Niazi, “Application of MIA for a QSAR Study of Inhibitory Activity of DHP Derivatives and Design of New Compounds Using WT and GA for Pixel Processing,” Polycyclic Aromatic Compounds 37, no. 5 (2017): 442–55.
  • Matthew Clark, Richard Cramer, Nicole Opdenbosch, and Richard Iii, “Validation of the General Purpose TRIPOS 5.2 Force Field,” Journal of Computational Chemistry 10, no. 8 (1989): 982–1012.
  • Jian-Bo Tong, Ding Luo, Shuai Bian, and Xing Zhang, “Structural Investigation of Tetrahydropteridin Analogues as Selective PLK1 Inhibitors for Treating Cancer through Combined QSAR Techniques, Molecular Docking, and Molecular Dynamics Simulations,” Journal of Molecular Liquids 335, (2021): 116235.
  • Richard D. Cramer, Phillip Cruz, Gunther Stahl, William C. Curtiss, Brian Campbell, Brian B. Masek, and Farhad Soltanshahi, “Virtual Screening for R-Groups, Including Predicted pIC50 Contributions, within Large Structural Databases, Using Topomer CoMFA,” Journal of Chemical Information and Modeling 48, no. 11 (2008): 2180–95.
  • Chandrabose Selvaraj, Sunil Tripathi, Karnati Reddy, and Sanjeev Kumar Singh, “Tool Development for Prediction of pIC50 Values from the IC50 values-A pIC50 Value Calculator,” Current Trends in Biotechnology and Pharmacy 5 (2011): 1104–09.
  • Svante Wold, A. Ruhe, H. Wold, and William Dunn, “The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses,” SIAM Journal on Scientific and Statistical Computing 5, no. 3 (1984): 735–743.
  • Robert J. Jilek and Richard D. Cramer, “Topomers: A Validated Protocol for Their Self-Consistent Generation,” Journal of Chemical Information and Computer Sciences 44, no. 4 (2004): 1221–7.
  • Shane Weaver and M. Paul Gleeson, “The Importance of the Domain of Applicability in QSAR Modeling,” Journal of Molecular Graphics & Modelling 26, no. 8 (2008): 1315–26.
  • Ming-Yang Wang, Jing-Wei Liang, Kamara M. Olounfeh, Qi Sun, Nan Zhao, and Fan-Hao Meng, “A Comprehensive In Silico Method to Study the QSTR of the Aconitine Alkaloids for Designing Novel Drugs,” Molecules (Basel, Switzerland) 23, no. 9 (2018): 2385.
  • Douglas B. Kitchen, Helene Decornez, John R. Furr, and Jurgen Bajorath, “Docking and Scoring in Virtual Screening for Drug Discovery: Methods and Applications,” Nature Reviews. Drug Discovery 3, no. 11 (2004): 935–49.
  • John J. Irwin, Teague Sterling, Michael M. Mysinger, Erin S. Bolstad, and Ryan G. Coleman, “ZINC: A Free Tool to Discover Chemistry for Biology,” Journal of Chemical Information and Modeling 52, no. 7 (2012): 1757–68.
  • H. Claussen, C. Buning, M. Rarey, and T. Lengauer, “FlexE: Efficient Molecular Docking considering Protein Structure Variations,” Journal of Molecular Biology 308, no. 2 (2001): 377–95.
  • Praveen M. Parkali, A. Shyam Kumar, Johanna K. Pohamba, Prodensia T. Shilomboleni, Sruthi Turaga, Vinod Shaiva, Gurubasavaraj V. Pujar, Shrinivas D. Joshi, Tejraj M. Aminabhavi, and Sheshagiri R. Dixit, “Molecular Docking and Three‐Dimensional Quantitative Structure–Activity Relationships for Antitubercular Pyrimidine Derivatives,” Polycyclic Aromatic Compounds (2021). doi: 10.1080/10406638.2021.1885455.
  • Amir Ghasemi, Reza Ranjbar, and Jafar Amani, “In Silico Analysis of Chimeric TF, Omp31 and BP26 Fragments of Brucella melitensis for Development of a Multi Subunit Vaccine Candidate,” Iranian Journal of Basic Medical Sciences 17, no. 3 (2014): 172–80.
  • Hongbin Yang, Chaofeng Lou, Lixia Sun, Jie Li, Yingchun Cai, Zhuang Wang, Weihua Li, Guixia Liu, and Yun Tang, “admetSAR 2.0: Web-Service for Prediction and Optimization of Chemical ADMET Properties,” Bioinformatics (Oxford, England) 35, no. 6 (2019): 1067–69.
  • Antoine Daina, Olivier Michielin, and Vincent Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, no. 1 (2017): 42717.
  • Christopher A. Lipinski, “Lead- and Drug-Like Compounds: The Rule-of-Five Revolution,” Drug discovery today. Technologies 1, no. 4 (2004): 337–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.